Rui Shi, Peichen Pan, Rui Lv, Chongqing Ma, Enhui Wu, Ruochen Guo, Zhihao Zhao, Hexing Song, Joe Zhou, Yang Liu, Guoqiang Xu, Tingjun Hou*, Zhenhui Kang*, Jian Liu*, High-throughput glycolytic inhibitor discovery targeting glioblastoma by graphite dots-assisted LDI mass spectrometry, Science Advances, 2022, 8, eabl4923.Guest editors for the following journals: Advanced Drug Delivery Reviews, Current Drug Targets, Evidence-Based Complementary and Alternative Medicine, Combinatorial Chemistry & High Throughput Screening.Editors and advisory editors for the following journals: Journal of Cheminformatics, Journal of Chemical Information and Modeling, International Journal of Molecular Sciences (Molecular Informatics Section), Frontiers in Pharmacology (associate editor of Experimental Pharmacology and Drug Discovery Section), Current Pharmaceutical Design, Chemical Biology & Drug Design, Mini-Reviews in Medicinal Chemistry, Theoretical Biology & Medical Modelling, Current Computer-aided Drug Design, Medicinal Chemistry, Computational and Mathematical Methods in Medicine, Genomics, Proteomics & Bioinformatics (2015~2017), Journal of Pharmaceutics, Journal of Molecular Graphics & Modeling, Heliyon.1992-1997 B.Sc, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.in Computational Chemistry, College of Chemistry and Molecular Engineering, Peking University, Beijing, China. 2002-2004 Postdoctor, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.2004-2009 Postdoctor and research scientist, College of Chemistry and Biochemistry, UCSD, USA.2009-2013 Professor, Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, China.2013-now Professor, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
DRAGON SLAYER ORCHESTRA SHEET MUSIC FOR VIOLIN 2 PROFESSIONAL
Phone: 0571-88208412 Education and Professional Experiences Email: or Room 446, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058
0 kommentar(er)
